|
USP14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.676360E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.479200E-03 |
| Normal-vs-Stage2 |
4.450100E-02 |
| Normal-vs-Stage3 |
6.431600E-04 |
| Normal-vs-Stage4 |
5.378100E-04 |
| Stage1-vs-Stage2 |
9.844400E-01 |
| Stage1-vs-Stage3 |
2.591200E-01 |
| Stage1-vs-Stage4 |
2.094000E-01 |
| Stage2-vs-Stage3 |
4.466400E-01 |
| Stage2-vs-Stage4 |
3.336000E-01 |
| Stage3-vs-Stage4 |
7.037000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.597680E-03 |
| Normal-vs-AfricanAmerican |
2.512400E-01 |
| Normal-vs-Asian |
1.081740E-02 |
| Caucasian-vs-AfricanAmerican |
2.991400E-01 |
| Caucasian-vs-Asian |
9.444400E-01 |
| AfricanAmerican-vs-Asian |
3.640000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.399000E-04 |
| Normal-vs-Female |
3.975000E-03 |
| Male-vs-Female |
2.742800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.304040E-02 |
| Normal-vs-Age(41-60Yrs) |
1.042660E-03 |
| Normal-vs-Age(61-80Yrs) |
5.818600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.371200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.227800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.675560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.010000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.996400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.924400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.729400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.908200E-01 |
| Classical-VS-Follicular |
2.175600E-02 |
| Classical-VS-Other |
6.255800E-02 |
| Classical-VS-Normal |
1.930330E-02 |
| Tall-VS-Follicular |
5.011000E-01 |
| Tall-VS-Other |
1.820960E-01 |
| Tall-VS-Normal |
1.891720E-02 |
| Follicular-VS-Other |
4.146600E-01 |
| Follicular-VS-Normal |
2.807200E-04 |
| Other-VS-Normal |
4.619200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.164650E-03 |
| Normal-vs-N1 |
1.406450E-04 |
| N0-vs-N1 |
2.356400E-01 |
|
|
